Circulating Carnosine Dipeptidase 1 Associates with Weight Loss and Poor Prognosis in Gastrointestinal Cancer - Arner, Peter; Henjes, Frauke; Schwenk, Jochen M.; Darmanis, Spyros; Dahlman, Ingrid; Iresjö, Britt-Marie; Naredi, Peter; Agustsson, Thorhallur; Lundholm, Kent; Nilsson, Peter; Rydén, Mikael (PloS one, 2015)
Keywords: Adenocarcinoma - blood; Adenocarcinoma - mortality; Adenocarcinoma - pathology; adult; Aged; albumin; Amino acids; Analysis; Antibodies; Apolipoproteins; Biomarkers; Biomarkers, Tumor - blood; Biotechnology; blood analysis; Cachexia; Cachexia - blood; Cachexia - mortality; Cachexia - pathology; Cancer; cancer prognosis; Carnosine; carnosine dipeptidase 1; Catabolism; clinical article; cohort analysis; Cohort Studies; controlled study; Design factors; Diabetes; digestive system cancer; Dipeptidase; Dipeptidases - blood; Disease; disease association; enzyme blood level; enzyme immunoassay; Female; Gallbladder diseases; Gastrointestinal cancer; Glioblastoma; Health aspects; Hospitals; human; Humans; Immunoassay; Insulin-like growth factor I; Kirurgi; Laboratories; Male; Malnutrition; Medical diagnosis; Medical prognosis; Metastases; Metastasis; Middle Aged; outcome assessment; Ovarian cancer; Oxidation; Pancreas; Pancreatic cancer; Pancreatitis; Patients; Plasma levels; Prognosis; Prostate cancer; Proteins; Proteomics; Quality of life; Rodents; Science; Screening; somatomedin C; Stomach Neoplasms - blood; Stomach Neoplasms - mortality; Stomach Neoplasms - pathology; Surgery; Survival Analysis; unclassified drug; validation process; Weight loss; weight reduction